Potential Role of Autoantibodies Belonging to the Immunoglobulin G-3 Subclass in Cardiac Dysfunction Among Patients With Dilated Cardiomyopathy (original) (raw)

Immunoglobulin Adsorption in Patients With Idiopathic Dilated Cardiomyopathy

rudolf kunze

Circulation, 2000

View PDFchevron_right

Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy

Gerd Wallukat

Journal of the American College of Cardiology, 2000

View PDFchevron_right

Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption

Gerd Wallukat

International Journal of Cardiology, 1996

View PDFchevron_right

Immunohistological Changes in Dilated Cardiomyopathy Induced by Immunoadsorption Therapy and Subsequent Immunoglobulin Substitution

Gerd Wallukat

Circulation, 2001

View PDFchevron_right

Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up

Gerd Wallukat

International Journal of Cardiology, 2004

View PDFchevron_right

Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting

Najma Latif

Journal of the American College of Cardiology, 1993

View PDFchevron_right

Autoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies

Alida Caforio

Lupus, 2005

View PDFchevron_right

Investigation of autoantibodies directed against tissue-specific myocardial antigens in dilated cardiomyopathy

Дмитрий Рябенко

Биополимеры и …, 1995

View PDFchevron_right

Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy

Oberdan Parodi

Journal of The American College of Cardiology, 1990

View PDFchevron_right

Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy

Noel Rose

Journal of the American College of Cardiology, 1990

View PDFchevron_right

High proportion of patients with end-stage heart failure regardless of aetiology demonstrates anti-cardiac antibody deposition in failing myocardium: humoral activation, a potential contributor of disease progression

Jose Flores

European heart journal, 2014

View PDFchevron_right

Autoimmunity in dilated cardiomyopathy

Bernhard Maisch

Heart Failure Reviews, 1996

View PDFchevron_right

Effects of protein A immunoadsorption in patients with chronic dilated cardiomyopathy

Ziya Kaya

Journal of Clinical Apheresis, 2010

View PDFchevron_right

Non-specific removal of antibodies in patients with idiopathic dilated cardiomyopathy: implications for xenotransplantation

Gerd Wallukat

The Journal of Heart and Lung Transplantation, 2004

View PDFchevron_right

Detection of antibodies in cardiac autoimmunity

Joris Delanghe

Clinica Chimica Acta, 2009

View PDFchevron_right

Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy

Wolfgang Hoffmann

American Heart Journal, 2010

View PDFchevron_right

Retrospective and perspectives in the immunology of cardiac diseases

Bernhard Maisch

Springer seminars in immunopathology, 1989

View PDFchevron_right

Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy

Andreas Mügge

Clinical Research in Cardiology, 2010

View PDFchevron_right

Anti-$beta;-adrenoceptor autoantibodies with $beta;-adrenergic agonistic activity in human dilated cardiomyopathy (DCM): Localization of two epitopes

Gerd Wallukat

Journal of Molecular and Cellular Cardiology, 1992

View PDFchevron_right

Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy

Alida Caforio

Journal of Clinical Pathology, 1999

View PDFchevron_right

Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity?

Alida Caforio

Journal of Autoimmunity, 1990

View PDFchevron_right

Cardiomyopathy - An approach to the autoimmune background

Gerd Wallukat

Autoimmunity reviews, 2017

View PDFchevron_right

IgG anti-cardiomyocyte antibodies in giant cell myocarditis

Matthew Pincus

Annals of clinical and laboratory science, 2008

View PDFchevron_right

Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndrome

Juan Figueroa

PROTEOMICS - Clinical Applications, 2012

View PDFchevron_right

Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression

Alida Caforio

1997

View PDFchevron_right

Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy

Irvin Goldenberg

Circulation Research, 1989

View PDFchevron_right

Autoantibodies in Heart Failure and Cardiac Dysfunction

Ziya Kaya

Circulation Research, 2012

View PDFchevron_right

Passive transfer of affinity-purified anti-heart autoantibodies (AHA) from sera of patients with myocarditis induces experimental myocarditis in mice

Alida Caforio

International Journal of Cardiology, 2015

View PDFchevron_right

The Effect of Intravenous Immunoglobulins on the Progression of Experimental Autoimmune Myocarditis in the Rat

Gad Keren

Experimental and Molecular Pathology, 2001

View PDFchevron_right

Immunoglobulin Isotype Determines Pathogenicity in Antibody-Mediated Myocarditis in Naive Mice

lionel zuckier

Circulation Research, 2000

View PDFchevron_right

Fcγ-Receptor IIa Polymorphism and the Role of Immunoadsorption in Cardiac Dysfunction in Patients With Dilated Cardiomyopathy

Wolfgang Hoffmann

Clinical Pharmacology & Therapeutics, 2010

View PDFchevron_right

Assessment of immune modulation of β-adrenergic pathways in human dilated cardiomyopathy: Influence of methodologic factors

Irvin Goldenberg

American Heart Journal, 1992

View PDFchevron_right

Discovering novel targets for autoantibodies in dilated cardiomyopathy

Cornelia Deeg

ELECTROPHORESIS, 2008

View PDFchevron_right

Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease‐associated protein chip

Derek Murphy

PROTEOMICS, 2006

View PDFchevron_right